On Invalid Date, Harpoon Therapeutics (NASDAQ: HARP) reported Q1 2023 earnings per share (EPS) of -$0.31, up 50% year over year. Total Harpoon Therapeutics earnings for the quarter were -$11.34 million. In the same quarter last year, Harpoon Therapeutics's earnings per share (EPS) was -$0.62.
As of Q2 2023, Harpoon Therapeutics's earnings has grown year over year. Harpoon Therapeutics's earnings in the past year totalled -$58.75 million.
What is HARP's earnings date?
Harpoon Therapeutics's earnings date is Invalid Date. Add HARP to your watchlist to be reminded of HARP's next earnings announcement.
What was HARP's revenue last quarter?
On Invalid Date, Harpoon Therapeutics (NASDAQ: HARP) reported Q1 2023 revenue of $8.58 million up 45.33% year over year. In the same quarter last year, Harpoon Therapeutics's revenue was $5.91 million.
What was HARP's revenue growth in the past year?
As of Q2 2023, Harpoon Therapeutics's revenue has grown 68.31% year over year. This is 2.04 percentage points lower than the US Biotechnology industry revenue growth rate of 70.34%. Harpoon Therapeutics's revenue in the past year totalled $34.59 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.